ArticleCirculation2025

Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke.

Alec Stepanian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.